Coelho Rogerio Vivaldi Sigilon Therapeutics, Inc. (SGTX) insider trading activity

Coelho Rogerio Vivaldi is PRESIDENT AND CEO of Sigilon Therapeutics, Inc.. Currently has a direct ownership of 0 shares of SGTX, which is worth approximately $0. The most recent transaction as insider was on Aug 11, 2023, when has been sold 12,169 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Coelho Rogerio Vivaldi Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 11 2023	SELL Sale (or disposition) back to the issuer	-	12,169 Reduced 100.0%	0 Common Stock
Jul 21 2023	BUY Exercise of conversion of derivative security	$106,358 $19.24 p/Share	5,528 Added 31.6%	11,963 Common Stock
Nov 04 2021	BUY Grant, award, or other acquisition	-	50,000 Added 40.5%	73,461 Common Stock
Dec 08 2020	BUY Conversion of derivative security	-	22,222 Added 50.0%	22,222 Common Stock

Also insider at

CRNX

Crinetics Pharmaceuticals, Inc. Healthcare

VTRS

Viatris Inc Healthcare

CRV